Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
74
days
A patent perspective of RSK inhibitors to treat cancer (2020-present)
Authors
Aviv Preminger; Deborah A. LanniganShow moreShow less
Affiliations
1. Vanderbilt University; 2. Vanderbilt University Medical CenterShow moreShow less
90
days
AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020–present)
Authors
Alfie M. Case; Melanie M. Smith; Cole A. Mack; Paul C. TrippierShow moreShow less
Affiliations
1. University of Nebraska Medical CenterShow moreShow less
110
days
Autotaxin inhibitors: an updated patent review (2021-present)
Authors
Xiujian Wei; Chengjing Zhao; Zhi Cao; Zehui Tan; Xin ZhaiShow moreShow less
Affiliations
1. Shenyang Pharmaceutical UniversityShow moreShow less
111
days
Recent patent landscape of ASK1 inhibitors: spotlight on 2-(1-isopropyl-4H-1,2,4-triazole-3-yl) pyridine as a privileged scaffold
Authors
Yash Kumar Gaur; Divyanshi Thakur; Shivam Nag; Kalicharan SharmaShow moreShow less
Affiliations
1. ISF College of Pharmacy; 2. Graphic Era Hill UniversityShow moreShow less
74
days
SLIT2 and ROBO-axis inhibitors for the treatment of cancer: a patent review (2020–2026)
Authors
Mahmoud Khatib Al-Ruweidi; Moustafa T. GabrShow moreShow less
Affiliations
1. Qatar University; 2. Weill Cornell MedicineShow moreShow less
100
days
An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)
Authors
Mennatallah Abdallah; Parthiena M. Keddis; Trevina M. Keddis; Dalia S. El-Gamil; Ashraf H. Abadi; Isao Kii; Matthias Engel; Mohammad Abdel-HalimShow moreShow less
Affiliations
1. German University in Cairo; 2. Ahram Canadian University; 3. Shinshu University; 4. Saarland UniversityShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days